LLY-2707
LLY-2707 is a selective glucocorticoid receptor (GR) antagonist. LLY-2707 is promising for research of diabetes and psychiatric disorders such as schizophrenia[1].
Product Specifications
CAS Number
[1621865-33-5]
UNSPSC
12352005
Target
Glucocorticoid Receptor
Related Pathways
Immunology/Inflammation; Vitamin D Related/Nuclear Receptor
Field of Research
Metabolic Disease; Neurological Disease
Smiles
CS(=O)(NC1=CC(C(C)(C)C)=CC2=C1NC(C)=C2C3=CC(F)=NC=C3C)=O
Molecular Formula
C20H24FN3O2S
Molecular Weight
389.49
References & Citations
[1]Sindelar DK, et al. LLY-2707, a novel nonsteroidal glucocorticoid antagonist that reduces atypical antipsychotic-associated weight gain in rats. J Pharmacol Exp Ther. 2014 Jan;348 (1) :192-201.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
41447151 3x 1.0 µg DNA
RPL32P9 CRISPR All-in-one AAV vector set (with saCas9)(Human)
Ask
View Details 
MBS2801945-01 48 Tests
Chicken Pituitary adenylate cyclase activating polypeptide (PACAP) ELISA Kit
Ask
View Details MBS2801945-02 96 Tests
Chicken Pituitary adenylate cyclase activating polypeptide (PACAP) ELISA Kit
Ask
View Details MBS2801945-03 5x 96 Tests
Chicken Pituitary adenylate cyclase activating polypeptide (PACAP) ELISA Kit
Ask
View Details